Editas Medicine (EDIT) Assets (QoQ) (2016 - 2025)

Editas Medicine (EDIT) Assets (QoQ) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn -
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn -
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn
7 Belite Bio 63.57 Bn 63.57 Bn -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn
10 Editas Medicine 241.46 Mn 94.82 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.54%
Sep 30, 2025 -4.19%
Jun 30, 2025 -20.13%
Mar 31, 2025 -22.82%
Dec 31, 2024 4.28%
Sep 30, 2024 -14.87%
Jun 30, 2024 -12.61%
Mar 31, 2024 -11.78%
Dec 31, 2023 -1.09%
Sep 30, 2023 -6.88%
Jun 30, 2023 16.77%
Mar 31, 2023 -9.76%
Dec 31, 2022 -3.15%
Sep 30, 2022 -8.57%
Jun 30, 2022 -6.78%
Mar 31, 2022 -8.03%
Dec 31, 2021 -5.51%
Sep 30, 2021 -5.14%
Jun 30, 2021 -3.13%
Mar 31, 2021 36.27%